Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
The Journal of Cell Biology|May 31, 2019
A balancing act: PHLPP2 fine tunes AKT activity and MYC stability in prostate cancerRoxanne Toivanen, Luc FuricDevelopment (Cambridge, England)|April 13, 2017
Prostate organogenesis: tissue induction, hormonal regulation and cell type specificationRoxanne Toivanen, Michael M ShenStem Cell Reports|April 28, 2016
Basal Progenitors Contribute to Repair of the Prostate Epithelium Following Induced Luminal AnoikisRoxanne Toivanen, Adithi Mohan, Michael M ShenCold Spring Harbor Perspectives in Medicine|January 10, 2018
Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant ModelsGail P Risbridger, Roxanne Toivanen, Renea A TaylorEndocrine-Related Cancer|July 28, 2010
Stem cells in prostate cancer: treating the root of the problemRenea A Taylor, Roxanne Toivanen, Gail P RisbridgerCell Reports|September 2, 2014
Luminal cells are favored as the cell of origin for prostate cancerZhu A Wang, Roxanne Toivanen, Sarah K Bergren, et al.Cancer Letters|October 23, 2021
Hidden clues in prostate cancer - Lessons learned from clinical and pre-clinical approaches on diagnosis and risk stratificationRoxanne Toivanen, Laura H Porter, Zhuoer Li, et al.Stem Cells (Dayton, Ohio)|May 18, 2012
Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 statusRenea A Taylor, Roxanne Toivanen, Mark Frydenberg, et al.Science Translational Medicine|May 31, 2013
A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumorsRoxanne Toivanen, Mark Frydenberg, Declan Murphy, et al.BJU International|November 16, 2021
Neuroendocrine cells in prostate cancer correlate with poor outcomes: a systematic review and meta-analysisAshwini Kannan, David Clouston, Mark Frydenberg, et al.Pageof 2